Gains, Losses, and Chipotle Salsa: The Market’s Spicy Mixture of Highs, Lows, and Tex-Mex Comebacks

VinFast and the Furious: Vietnamese EV Maker Revs Up for $27B SPAC-tacular US Debut

TLDR:
VinFast plans to go public in the US through a SPAC merger, valuing the company at $27 billion, with expectations to tap into the resources and expertise of experienced investors to ride the wave of the booming global electric vehicle market. However, VinFast will face the same regulatory requirements and controls as any other public company, and competition from established EV makers.

Ladies and gentlemen, gather ’round for a riveting tale of electric vehicles, international intrigue, and the audacity of a Vietnamese car maker looking to take on the likes of Tesla in the United States. VinFast, known for its innovative and affordable electric cars, has announced its plan to go public in the US through a merger with a yet-to-be-named special purpose acquisition company (SPAC). This cunning maneuver bypasses the traditional IPO process and aims to quickly raise capital, while also valuing VinFast at a whopping $27 billion (pause for dramatic effect).

Now, you might be thinking, “Why would VinFast want to dive into the shark-infested waters of the US electric vehicle market?”, especially with the notable presence of Tesla. Fear not, for VinFast has a plan. By merging with an already listed SPAC, the company expects to tap into the resources and expertise of experienced investors, allowing them to potentially ride the wave of the booming global electric vehicle market, which is expected to reach $803.81 billion by 2027.

Of course, with great power comes great responsibility. VinFast will be subject to the same regulatory requirements and controls as any other public company, which might be a touch inconvenient for a newcomer to the American market. Additionally, there’s the small matter of competition from established electric car makers who might not be too thrilled about a new kid on the block trying to steal their thunder.

However, VinFast isn’t cowering in fear or trembling at the prospect of competition. No, they have a talented team of engineers and designers determined to create innovative, sustainable electric vehicles that could give Tesla a run for its money. And with the backing of some of the world’s leading investors, VinFast seems to be in it for the long haul.

In conclusion, VinFast’s decision to go public in the US through a merger and acquisition sets the stage for a fascinating chapter in the electric vehicle market. As the saying goes, “fortune favors the bold,” and VinFast’s bold move to tap into the US market could potentially pay off in a big way. Though the electric vehicle market is already quite crowded, it looks like there’s always room for one more party crasher.

Now, as we wait with bated breath to see how VinFast fares in this thrilling saga, we can’t help but wonder if their electric scooters and cars will be embraced by American consumers. After all, with the ever-increasing demand for sustainable transportation and governments pushing for reduced carbon emissions, VinFast could be just what the doctor ordered. So, stay tuned, dear readers, and enjoy the ride as the electric vehicle market gets a little more… electrifying.

Disclaimer

Eye Spy with My Bionic Eye: Paul Bresge’s Back to Tackle Rare Retinal Diseases with $100M and a Gene Therapy Twist

TLDR:
Ray Therapeutics raised $100M in Series A funding for RTx-015, a gene therapy to treat retinitis pigmentosa, and will expand into other rare eye diseases. The treatment is expected to enter Phase I trials next year, with the potential to transform the lives of millions worldwide.

Ladies and gentlemen, take off your glasses and listen closely, for a new eye solution has arrived in town! Ray Therapeutics, led by the visionary Paul Bresge, has raised a staggering $100 million in Series A funding for a breakthrough gene therapy to treat rare degenerative retinal diseases. With RTx-015, Ray Therapeutics is poised to transform the lives of millions suffering from retinitis pigmentosa, a disease with no known cure that affects millions worldwide. This innovative treatment is expected to enter Phase I trials next year, taking a significant step forward in the field of ophthalmology.

But wait, there’s more! The $100 million funding will not only fuel the global clinical trials for RTx-015 but will also bankroll the company’s expansion into other rare and degenerative eye diseases such as Stargardt’s disease and geographic atrophy, a leading cause of blindness. This funding will propel Ray Therapeutics to new heights, enabling the company to take its research to the next level and develop treatments for other debilitating eye conditions.

The future looks bright indeed, as the initiation of the global clinical trial for RTx-015 marks a significant stride forward in the world of ophthalmology. This progress is a testament to the unwavering dedication of the Ray Therapeutics team and the foresight of Paul Bresge. With the raised funds, the company is well on its way toward achieving the ultimate goal of finding a cure for rare degenerative eye diseases. It’s crucial that we band together to support this groundbreaking development, which has the potential to transform the lives of millions around the world.

Now, let’s take a closer look at the revolutionary RTx-015 gene therapy, which works by delivering a functional copy of the affected gene to the cells in the retina. This ingenious approach helps restore cell function and prevent disease progression. The best part? The treatment is on track to enter Phase I trials next year, making it one step closer to becoming a reality for those suffering from this debilitating disease. This would be a game-changer for the millions of people around the world who are afflicted by such conditions.

What does all this mean for the future of ophthalmology? In a nutshell, we are closing in on a treatment for a rare degenerative eye disease, enabling millions of people worldwide to live better, healthier lives. Paul Bresge and Ray Therapeutics are at the forefront of this revolutionary movement, pushing the boundaries of what’s possible in the realm of eye care.

In conclusion, the world of ophthalmology is on the cusp of a major breakthrough, thanks to the tireless efforts of Paul Bresge and the talented team at Ray Therapeutics. With the clinical trial of RTx-015 and the expansion into other rare eye diseases, the company is poised to change the game in the treatment of these debilitating conditions. As we watch this revolutionary development unfold, let us remember to support the trailblazing endeavors of those working to improve the lives of millions suffering from rare degenerative eye diseases. The future is bright, and it’s all thanks to the innovative minds at Ray Therapeutics.

Disclaimer

Schmid Goes Public: From Iron Foundry to NYSE in Just 158 Years!

TLDR:
Schmid Group merges with Pegasus Digital Mobility Acquisition Corp to become a $640 million NYSE-listed company, marking SPACs’ shift to stable targets. Schmid Group’s majority ownership and management positions will remain while aiming to accelerate growth and expand into new markets, including the automotive sector, with the help of Pegasus’s experienced team.

In the world of business, where money talks and innovation takes a back seat, it’s a pleasure to witness a company with over a century of history shake things up with a public debut. The Schmid Group, a German powerhouse of advanced electronics manufacturing technology, has decided to do just that as they leap into the wild, wacky world of the New York Stock Exchange. And who better to guide them into this new era than an auto industry veteran called Ralph Speth, and his blank-check company, Pegasus Digital Mobility Acquisition Corp?

The merger with Pegasus Digital Mobility Acquisition Corp. has left Schmid Group in a pretty cozy spot, valuing the family-owned company at $640 million, including debt. This isn’t just another deal in the cutthroat world of special-purpose acquisition companies (SPACs). No, this marks a significant shift, as SPACs are now targeting growing, profitable ventures after getting a little too cozy with wobbly startups in 2020 and 2021. It seems that SPACs have finally learned from their past mistakes and are setting their sights on more stable targets.

Schmid Group’s roots can be traced back to 1864 as an iron foundry in Freudenstadt, a picturesque town in the heart of the Black Forest. This is a place where fresh air and lush trails are aplenty, but don’t be fooled by its fairytale-like setting; Schmid Group has been hard at work creating technologies for industries such as renewable power and energy storage. With over 800 employees under its umbrella, Schmid has been responsible for developing equipment and manufacturing processes for printed circuit boards. But don’t worry, the Schmid family isn’t going anywhere. They will maintain majority ownership and retain management positions after the listing on the New York Stock Exchange.

Christian Schmid, the company’s CEO, shared his enthusiasm for the upcoming endeavor, stating that becoming an NYSE-listed company will strengthen Schmid’s position as a global solutions provider and accelerate their growth trajectory and innovation. It’s truly heartwarming to see a company wanting to excel not just for the sake of profit but also for the betterment of all stakeholders involved.

On the other side of this partnership, Pegasus Digital Mobility Acquisition Corporation raised $200 million in its October 2021 IPO and has been looking for deals in areas such as next-generation transportation. Backed by StratCap, an investment firm focused on digital infrastructure, Pegasus CEO Speth has over 20 years of experience with BMW AG and played a significant role in running Jaguar Land Rover after its sale to India’s Tata Motors.

With the experienced team of former Morgan Stanley investment banker F. Jeremy Mistry as the SPAC’s CFO, and ex-Jaguar Land Rover executive Stephen Berger as CIO, Speth had this to say about the partnership: “We are excited to partner with the Schmid team to further grow the group’s platform and accelerate expansion into new attractive markets, including the automotive sector.” It seems like a match made in heaven, or at least a very productive conference room.

So, dear readers, as we celebrate this partnership between Schmid Group and Pegasus Digital Mobility Acquisition Corporation, let’s take a moment to appreciate the power of forward-thinking collaboration and the value of continuous innovation in the technology industry. In a world where the pace of change is breakneck, it’s refreshing to see that some companies still prioritize staying ahead of the curve. Here’s to Schmid Group’s future success and the endless possibilities they will undoubtedly create.

Disclaimer

Delaware Drama: Super Group Shareholders Sue Shady SPAC Schemers for $4.75 Billion Merger Mishap

TLDR:
Super Group shareholders accused of withholding information during merger to profit from stock price decline. Defendants gifted shares valued at 0.0023 cents each, sold for $1 each with waived redemption rights, encouraging stockholders to not exercise redemption rights and vote in favor of the merger.

Oh, what a tangled web we weave, my dear readers, when at first we practice to deceive. This time, we’re peering into the case of the Super Group shareholders, designers of the Sports Entertainment Acquisition Corporation (SEAC), who face accusations of withholding information during their $4.75 billion merger. And why, pray tell, would they do such a thing? Well, it seems that Grubman, Shumway, and Collins, the trio of defendants, orchestrated this charade in order to profit from transactions that would cause a post-merger stock price decline. They allegedly achieved this by structuring their blank-check company in a way that ensured a bad deal would be more profitable than no deal at all. Clever, isn’t it?

Before SEAC’s initial public offering (IPO), our defendants were gifted 11.25 million common equity shares, valued at a mere 0.0023 cents per share. But that’s just the beginning of this caper. You see, under the terms of the special purpose acquisition company’s IPO, these gentlemen, along with an unnamed investor, sold their shares for a whopping $1 each. But wait, there’s more! They cunningly waived their redemption rights for the founder’s shares, making it critical for the SPAC to complete a merger with a partner, lest the shares expire worthless. It’s a convoluted scheme worthy of any pulp detective novel.

According to the complaint filed in the Delaware Court of Chancery, the defendants knew that even a bad deal driving SEAC’s stock price below $10 per share would be more advantageous than no deal at all. They also knew that they could maximize the trust funds needed for the merger by limiting the number of redemptions – a move that would deplete cash from the same trust. Talk about covering your bases.

Now, as you may know, a standard timeframe for a SPAC to find a merger partner is usually set at two years. If it fails, the shell company is liquidated, cash goes back to the shareholders, and the founders are left without profits. But these defendants allegedly had other plans. They encouraged public Class A stockholders not to exercise their redemption rights and urged them to vote in favor of the merger. Quite the intricate ploy, don’t you think?

When Super Group revealed its preliminary Q4 and FY22 results in mid-March, they expressed optimism for the future, despite a year-on-year decline in several financial metrics. They claimed the value of shares was $10 apiece, but the plaintiffs’ legal team begs to differ, arguing that the actual value was closer to $6.72 per share due to cash declines and dilution. The defendants were also accused of being privy to upcoming “substantial redemptions” that would cut the per share cash contribution – another piece of damning evidence.

The plaintiffs’ counsel is currently seeking damages to reveal the difference between the value stockholders would have experienced if they had redeemed their shares before the merger and the genuine value of the shares they ultimately received. As this lawsuit continues to unfold, one can’t help but wonder if these defendants will get their just desserts or if they’ll manage to slip through the cracks of the legal system. Only time will tell, dear readers, but rest assured, we’ll be watching closely.

Disclaimer

VinFast IPO: Fast & Electrious – Vietnamese Automaker Charges into US Market with $27 Billion Valuation

TLDR:
Vietnamese automaker VinFast is preparing for its U.S. IPO after agreeing on a business combination with Black Spade Acquisition Company, with an equity value of $23 billion and an enterprise value of $27 billion. VinFast has already delivered four EV models in Vietnam and is expanding its reach in Europe and the U.S. with a manufacturing hub in North Carolina. Existing VinFast shareholders will own approximately 99% of the combined company once the transaction is completed and approved.

Ladies and gentlemen, hold onto your hats, because the world of automaking is about to get a whole lot more interesting. VinFast Auto, a rather ambitious Vietnamese car brand, is on the fast track to finally achieving its long-awaited U.S. IPO, thanks to a business combination agreement with the quite mysterious Black Spade Acquisition Company. With a proposed enterprise value of $27 billion and an equity value of $23 billion, it’s safe to say VinFast is not exactly playing small potatoes here.

The young automaker has already made quite a dent in its native Vietnam, having delivered four different EV models, and is simultaneously expanding its reach to Europe and preparing to break ground in North Carolina for its US manufacturing hub. It seems VinFast is moving at lightning speed, outpacing even the most well-established automakers on the planet, with global expansion plans as ambitious as its proposed valuation.

But such grand plans require equally grand funding, as evidenced by VinGroup chairman Pham Nhat Vuong’s recent $1 billion personal contribution to the cause. With this level of financial commitment, it’s clear that VinFast is not content to simply be a regional contender; it has its sights set on the international stage and is prepared to put its money where its mouth is.

The upcoming IPO, which has been a hot topic of discussion since VinFast first made its intentions known several years ago, is now one step closer to reality. By combining forces with Black Spade Acquisition Company, VinFast is solidifying its position in the market and gearing up for a big splash on the New York Stock Exchange. Once the transaction is completed and approved, existing VinFast shareholders will own approximately 99% of the combined company, demonstrating a level of confidence in the automaker’s future that is nothing short of astounding.

With the automotive industry in the midst of a once-in-a-century transformation, VinFast’s focus on electric vehicles puts it in an enviable position to capitalize on the shift away from petrol-powered cars. The company has already proven its ability to quickly enter international markets, as evidenced by the recent delivery of the VF 8 to customers on the West Coast of North America. With expansions underway in Europe and the imminent groundbreaking of its North Carolina facility, VinFast’s future is looking brighter than ever.

The closing of the transaction is expected to occur in the second half of 2023, subject to the usual regulatory and shareholder approvals. And once that happens, there’s no telling what heights this plucky Vietnamese automaker will reach. So, buckle up, my friends: VinFast is poised to take the automotive world by storm, and we’re all in for one heck of a ride.

In conclusion, VinFast’s daring leap into the world of electric vehicles and global markets is an impressive testament to the company’s courage, determination, and innovative spirit. The upcoming IPO and business combination agreement with Black Spade Acquisition Co will not only provide the capital needed to fuel VinFast’s ambitious plans, but also serve as a ringing endorsement of the market’s confidence in the automaker’s future. So, keep your eyes peeled, folks; VinFast is about to embark on a remarkable journey, and we wouldn’t want to miss a single moment of it.

Disclaimer

Arqit Quantum’s Satellite Side Hustle: A Cosmic Cash-In to Focus on Cybersecurity Awesomeness

TLDR:
Arqit Quantum has sold its satellite business to focus on cybersecurity and generate additional capital. The move allows the company to streamline its operations and provide cutting-edge solutions for its customers.

In a rather surprising turn of events, British cybersecurity start-up Arqit Quantum has announced its decision to sell its satellite business, boldly stepping away from its partnership with the now-bankrupt Virgin Orbit. But fear not, dear reader, for this seemingly abrupt move is all part of a master plan. Arqit Quantum is shedding some weight, bidding adieu to its satellite business, and diving headfirst into the rapidly expanding world of cybersecurity.

Now, you may be asking yourself, “Why would a company as focused on space-based cybersecurity solutions as Arqit Quantum suddenly sell its satellite business?” Well, my friends, the answer lies within the great cosmic dance of business strategy and financial decision-making. You see, as the old saying goes, one must break a few eggs to make an omelette, and in this case, Arqit Quantum is serving up a delicious cybersecurity omelette while discarding its satellite eggshells. The additional capital generated from this sale will allow the company to pursue its core business objectives without the distraction of orbiting hardware.

While the details of the transaction remain shrouded in mystery, one thing is certain: Arqit Quantum sees this as an opportunity more than a setback. By streamlining its operations and focusing solely on cybersecurity, the company can innovate and provide cutting-edge solutions for its customers, ensuring the highest level of security for critical data. In today’s increasingly digital world, the need for top-notch cybersecurity solutions has never been more vital. So, as the satellite side of the business drifts away, Arqit Quantum is committed to harnessing its full potential in the cybersecurity realm.

Let’s take a moment to bid farewell to the satellite business and welcome Arqit Quantum’s full immersion into the world of cybersecurity. For a company that has experienced its fair share of ups and downs, this bold move signifies a fresh start and a renewed focus on its core mission. With the world’s critical data at stake, Arqit Quantum’s decision to double down on cybersecurity could not have come at a better time.

As we watch Arqit Quantum embark on this exciting journey, it’s important to remember that even the most seemingly perfect plans can go awry. In the great cosmic dance of business, sometimes you have to pivot, shift, and shimmy your way through obstacles and challenges. The important thing is to keep moving forward, and that’s precisely what Arqit Quantum is doing with its decision to sell its satellite business.

In conclusion, my friends, keep an eye on Arqit Quantum as it ventures forth into the world of cybersecurity with renewed vigor. With its satellite business now a thing of the past, the company is poised to make an even greater impact in the ever-evolving landscape of digital security. So, let us raise a toast to Arqit Quantum’s future success and thank them for reminding us that sometimes, the best path forward is to let go of what no longer serves us and focus on what truly matters.

Disclaimer

Stem Cell Slytherins Unite: Calidi’s Trojans Merge with FLAG for a Cancer-Kicking Bonanza

TLDR:
Calidi Biotherapeutics plans to merge with First Light Acquisition Group (FLAG) and trade on NYSE American starting in July, with an expected valuation of $335 million and total proceeds of up to $82 million, aiming to revolutionize cancer treatment with its allogeneic stem cell-based technology. Calidi’s universal delivery system brings the price down from $500,000 to under $10,000, offering a revolutionary and inexpensive solution for treating cancer.

Ladies and gentlemen, gather around, for I have some thrilling news. If you’ve been waiting for stem cell-based oncolytic virus delivery platform companies to merge with special purpose entities, then today is your day! Calidi Biotherapeutics plans to join forces with First Light Acquisition Group (FLAG) and trade on the NYSE American under the ticker symbol “CLDI” starting in July. With an expected valuation of a cool $335 million, total proceeds from the transaction could reach up to $82 million. You know what they say, nothing says cutting-edge medical technology like a few extra million dollars.

The merger with FLAG will give Calidi the opportunity to tap into an extensive network and operational experience, addressing missions of national and global importance in the United States. This comes after Calidi’s previous merger attempt with Edoc Acquisition Corp, which ended prematurely due to Edoc’s inability to meet all the conditions in time. Well, you know what they say, if at first you don’t succeed, try merging with another company.

Calidi’s CEO, Allan Camaisa, is understandably excited about the partnership with FLAG. Their allogeneic stem cell-based technology could revolutionize cancer treatment, and they’re working with the federal government to fund these therapies. General James Cartwright, who served as Vice Chairman of the Joint Chiefs of Staff under two presidential administrations, is part of FLAG’s team. That’s right, folks – the military might help us fight cancer!

The California Institute for Regenerative Medicine (CIRM) has awarded Calidi a $3.1 million grant, while City of Hope received a $12 million grant for a clinical trial to evaluate Calidi’s licensed NeuroNova platform in patients with advanced brain cancer. Now, if that’s not progress, I don’t know what is.

Calidi has two therapies in clinical development – NeuroNova and SuperNova – which use stem cell-protected oncolytic viruses to target cancerous tumors. CEO Camaisa describes stem cells as a “Trojan horse” that hides viruses from the body’s immune system. Now, who wouldn’t want a sly little Trojan horse to help them fight cancer?

Unlike personalized delivery systems that cost up to $500,000 per patient, Calidi’s therapeutic approach is a universal delivery system. They aim to bring the price down from $500,000 to under $10,000 and even hundreds of dollars in the future. It’s a revolutionary and inexpensive solution for treating cancer, giving everyone a chance to access cutting-edge clinical trials and approved drugs, not just the wealthy with exceptional insurance programs.

Calidi’s master stem cell bank was derived from liposuction of mesenchymal stem cells from healthy adult adipose tissue (waist fat). So, the next time you’re feeling guilty about that extra piece of cake, remember that your love handles are just a stem cell goldmine waiting for their chance to shine.

In conclusion, the merger of Calidi Biotherapeutics and First Light Acquisition Group is a beacon of hope for cancer patients and investors alike. With their innovative stem cell-based technology and strategic partnerships, Calidi is on the cutting edge of revolutionizing cancer treatment. And with a goal of making these treatments affordable and accessible for everyone, they’re truly committed to changing lives. So, here’s to Calidi Biotherapeutics and their tireless efforts to bring life-changing treatments to patients around the world.

Disclaimer

SPAC Fat Projects and Avanseus: A Merged-in-Heaven Romcom Stuck on the “Merging Soon” Cliffhanger

TLDR:
Phat Projects and Avanseus merger deadline extended to June 15. Phat Projects received a notice of noncompliance from Nasdaq, but vows to resolve the issue and remain on the prestigious exchange.

Hold onto your hats, folks, because the thrilling saga of Phat Projects Acquisition Corp. continues with yet another deadline extension for their highly anticipated merger with Avanseus. The suspense is palpable, as the merger deadline shifts from May 15 to June 15, which is, coincidentally, just enough time to binge-watch your favorite series and still have time to spare.

In case you’ve been living under a rock, this SPAC (Special Purpose Acquisition Company) has been a staple of the business pages since it announced its merger plans in August last year. For those who are fans of plot twists, the deadline has been extended several times. Talk about a rollercoaster ride, right? Meanwhile, Singapore-based Avanseus must be itching to release its AI-based software solutions into the wild.

Our protagonist, Fat Projects, has had its fair share of ups and downs since going public in October 2021, raising a cool $100 million (which we can all agree is a rather impressive number). It’s like a beautiful, shiny beacon of hope in the otherwise drab world of finance, tirelessly pursuing innovative opportunities in the technology space. However, one cannot ignore the minor hiccups that have arisen along the way.

Earlier this month, Fat Projects received a little love letter from Nasdaq, notifying them that they were out of compliance with certain listing requirements. But fear not, dear reader, for this is merely a bump in the road. The company has vowed to do everything in its power to resolve these pesky issues and remain on the prestigious Nasdaq’s good side.

Despite these setbacks, the Fat Projects-Avanseus merger remains at the top of their priority list. It’s important to stay focused on the big picture, after all. And what a picture it is, with the promise of a powerful partnership that will bring immense value to both companies and place them at the forefront of the AI-based software solutions industry.

In an act of unwavering commitment, Fat Projects has assured its followers that the outstanding issues will be tackled swiftly and efficiently. After all, as we’ve learned from decades of watching sports movies, it’s not about the setbacks – it’s about the triumphant comeback.

So, dear readers, let us not despair at the extension of this merger deadline. Instead, let us rejoice in the knowledge that Fat Projects and Avanseus are working tirelessly to ensure the best possible outcome for their union. And when that glorious day finally arrives, the tech industry will surely tremble at the combined force of these two titans.

In the meantime, let us all sit back, relax, and enjoy the anticipation. Because as the old saying goes: good things come to those who wait. And in the case of the Fat Projects-Avanceus merger, the best is yet to come.

Disclaimer

Blue Ocean Dives into Asian Digital Media, Merges with TNL Mediagene – Upping Their Game in the Innovation Pool

TLDR:
TNL Mediagene merges with Blue Ocean Acquisition, receiving a valuation of $275 million USD and expanding in Japan, Taiwan, and Southeast Asia. The merger creates a media powerhouse that caters to millennials and Gen Z with a brand portfolio of Chinese, Japanese, and English digital products.

Well, folks, gather around for the latest in media matchmaking: Blue Ocean Acquisition has locked hands with the innovative TNL Mediagene in Asia. That’s right, this blank check company seems to have found its perfect match, a concept which many of us can only dream of. Now, this dynamic duo (formed after the merger of Taipei-based The News Lens and Tokyo-based Mediagene) is stepping up their game by going public in the United States and expanding in Japan, Taiwan, and Southeast Asia. The future of digital media is looking peachy, isn’t it?

Now, let’s talk money. We all know that’s what makes the world go round, right? This glorious partnership has bestowed upon TNL Mediagene a valuation of about $275 million USD. Not too shabby, if you ask me. It seems this whole politically neutral content gig is paying off. Who knew that providing news, business, and other snackable topics that won’t trigger any political outbursts would be such a lucrative endeavor?

This media powerhouse is well-equipped to cater to the ever-so-finicky millennials and Gen Z. You know, the ones that can’t decide whether they like avocado toast or TikTok dances more. With a brand portfolio of Chinese, Japanese, and English digital products, TNL Mediagene is truly the Swiss Army knife of news. This merger is a testament to the hard work and dedication of the TNL Mediagene team, who’ve shown an unwavering commitment to excellence and innovation. They must be patting themselves on the back right now, and deservedly so.

Blue Ocean Acquisition, the proverbial cupid of this transaction, has proven its ability to seek out and support innovative companies like TNL Mediagene that have the potential to change the world for the better. Well, at least the world of digital media. Kudos to them for spotting a gem and helping it shine brighter. And let’s not forget the investors, employees, and customers who also stand to benefit from this alliance. Cheers to all the stakeholders involved in this media matrimony.

Now, all we have to do is wait for the deal to close, expected to happen in the first quarter of 2024. Just think about it: we’ll be welcoming the new year, possibly nursing a hangover, and witnessing the birth of a media titan. Talk about hitting the ground running.

In conclusion, it’s safe to say that this merger has added a bit of spice to the digital media landscape. Blue Ocean Acquisition and TNL Mediagene are showing us that politically neutral content is not only in demand but is also a force to be reckoned with. As for the future of digital media, it seems to be heading in the right direction, and we can’t wait to see how this partnership unfolds. So, here’s to the happy couple, proving that when two innovative forces join hands, great things can happen. And remember, folks, stay hungry, and stay stupid!

Disclaimer

Roll Call at the Sheraton: Shareholders Invited to Bask in the Glory that is VAM Investments’ Annual General Meeting

TLDR:
– The Annual General Meeting of VAM Investments SPAC B.V. is a crucial event for shareholders to cast their votes on various issues, including management existence, financial results, compensation report, and discharge of directors.
– Shareholders can attend the meeting by holding shares in the company’s capital by May 30, 2023, and registering their intent to attend by June 20, 2023, either through their bank or brokerage firm or by email to info@vaminvestments-spac.com.

Fellow shareholders, gather ’round! It’s that fantastic time of the year again when we congregate in a stuffy conference room and cast our votes on issues like whether the company’s management should continue to exist. Yes, the lovely folks at VAM Investments SPAC B.V. cordially invite you to their Annual General Meeting, which is set to take place in the lap of luxury – the Sheraton Amsterdam Airport Hotel & Conference Center on June 27, 2023.

Now, you may think that annual meetings are just an opportunity for free cookies and coffee, but I assure you, the future of VAM Investments SPAC B.V. depends on this riveting event. With an agenda chock-full of discussion items and decision-making opportunities, rest assured that you’ll be kept on your toes. The management has even been kind enough to publish their 2022 Annual Report on their website and in Milan, Italy, so you can peruse it at your leisure.

Of course, you can’t have a shareholder meeting without discussing the Management Report for Fiscal Year 2022. So, buckle up for a thrilling presentation on the company’s financial results, where you’ll have the chance to voice your thoughts and concerns. And in the true spirit of democracy, you’ll also get to cast an advisory vote on the oh-so-important Compensation Report for Fiscal Year 2022. This will give you a sneak peek into the individual remuneration of the Executive Committee members, and your vote will help decide whether their pockets should continue to be lined.

But wait, there’s more! The meeting will also include proposals to grant discharge to both executive and non-executive directors of the company. This means you get to decide if they should be forgiven for their performance in the 2022 financial year. Just remember, their obligations must be evident from the Annual Report or disclosed to the General Assembly before the adoption of the financial statements.

Now, I know you’re all dying to know about the re-appointment of the external auditor for the financial year 2023. Well, fear not, as the proposal is to extend the current external audit contract with Mazars Accountants N.V. by one whole year. Your vote could help decide whether they continue to keep a close eye on the company’s financial statements.

And just when you thought it couldn’t get any more exhilarating, the floor will be open for any other relevant business you’d like to discuss during the AGM. So, bring your sharpest insights, dear shareholders, and prepare to engage in stimulating conversation.

To attend this not-to-be-missed event, simply ensure you hold shares in the company’s capital by May 30, 2023. Then, register your intent to attend, either by notifying your bank or brokerage firm by June 20, 2023, or by email to info@vaminvestments-spac.com. Once that’s sorted, you’ll be all set to cast your votes and make your voice heard.

So, mark your calendars for June 27, and ready your finest business attire. The Annual General Meeting of VAM Investments SPAC B.V. promises to be a whirlwind of excitement, enlightenment, and, of course, cookies and coffee. Don’t miss your chance to play a pivotal role in shaping the company’s future – and, who knows, maybe even snag a few extra snacks for the road.

Disclaimer